• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于研究蛋白激酶CK2对p53肿瘤抑制蛋白磷酸化作用的新型系统。

A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.

作者信息

McKendrick L, Meek D W

机构信息

Biomedical Research Centre, Ninewells Hospital and Medical School, University of Dundee, UK.

出版信息

Cell Mol Biol Res. 1994;40(5-6):555-61.

PMID:7735330
Abstract

The tumor suppressor protein p53 is phosphorylated at a C-terminal residue (serine 386 in mouse p53) by the protein kinase CK2. Phosphorylation by CK2 activates the specific DNA binding function of p53 and stimulates its ability to suppress cellular growth. Previous reports have suggested that phosphorylation of p53 at the CK2 site is stimulated in cells expressing the large tumor antigen (T antigen) of simian virus 40 (SV40). To test this idea, we have expressed a C-terminal p53 "mini-protein" which comprises amino acids 154-387 of mouse p53 and therefore lacks the heavily phosphorylated N-terminus. In addition, the serine 309 phosphorylation site (targeted by cyclin-dependent kinases) has been mutated to encode alanine. We have expressed the p53 mini-protein in mammalian cells and shown by phosphopeptide mapping that it is phosphorylated at a single physiological phosphorylation site, serine 386. Using this mini-protein as a cellular target for CK2, we have shown that phosphorylation of p53 by CK2 is not affected by the presence of T antigen. The p53 mini-protein is likely to be a useful tool with which to probe the regulation of p53 phosphorylation by CK2 in response to other factors which influence cell growth.

摘要

肿瘤抑制蛋白p53在其C末端残基(小鼠p53中的丝氨酸386)处被蛋白激酶CK2磷酸化。CK2介导的磷酸化激活了p53的特异性DNA结合功能,并增强了其抑制细胞生长的能力。先前的报道表明,在表达猿猴病毒40(SV40)大肿瘤抗原(T抗原)的细胞中,p53在CK2位点的磷酸化受到刺激。为了验证这一观点,我们表达了一种C末端p53“小蛋白”,它包含小鼠p53的第154 - 387位氨基酸,因此缺少高度磷酸化的N末端。此外,丝氨酸309磷酸化位点(细胞周期蛋白依赖性激酶的作用靶点)已被突变为编码丙氨酸。我们在哺乳动物细胞中表达了p53小蛋白,并通过磷酸肽图谱分析表明它在单个生理磷酸化位点丝氨酸386处被磷酸化。以这种小蛋白作为CK2的细胞靶点,我们发现CK2对p53的磷酸化不受T抗原存在的影响。p53小蛋白可能是一种有用的工具,可用于探究CK2对p53磷酸化的调控,以响应其他影响细胞生长的因素。

相似文献

1
A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.一种用于研究蛋白激酶CK2对p53肿瘤抑制蛋白磷酸化作用的新型系统。
Cell Mol Biol Res. 1994;40(5-6):555-61.
2
Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.与来自SV40转化大鼠细胞的p53-大T免疫复合物相关的蛋白激酶活性的鉴定
Oncogene. 1993 Aug;8(8):2193-205.
3
Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.生长抑制蛋白p53与蛋白激酶CK2调节性β亚基相互作用位点的图谱绘制。
Oncogene. 1995 Nov 16;11(10):1971-8.
4
Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.一种被SV40大T抗原激活并使肿瘤抑制蛋白p53磷酸化的蛋白激酶的纯化与鉴定。
Oncogene. 1995 Mar 16;10(6):1175-85.
5
Characterization of protein kinase CK2 protein subunits and p53 in F9 teratocarcinoma cells in the absence and presence of cisplatin.顺铂存在和不存在的情况下,F9畸胎癌细胞中蛋白激酶CK2蛋白亚基和p53的特征分析
Cell Mol Biol Res. 1994;40(5-6):587-92.
6
Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.蛋白激酶CK2可消除蛋白激酶C对潜在p53蛋白DNA结合能力的激活作用。
Biochem J. 2004 Mar 15;378(Pt 3):939-47. doi: 10.1042/BJ20030662.
7
Phosphorylation by DNAPK inhibits the DNA-binding function of p53/T antigen complex in vitro.DNA依赖蛋白激酶介导的磷酸化作用在体外可抑制p53/T抗原复合物的DNA结合功能。
Anticancer Res. 1999 May-Jun;19(3A):2079-83.
8
DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.DNA损伤引发人p53在CK2位点的DRB抗性磷酸化。
Oncogene. 1998 Aug 27;17(8):1045-52. doi: 10.1038/sj.onc.1202014.
9
Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.p53的特异性DNA结合不依赖于酪蛋白激酶II位点丝氨酸389处的突变。
Oncogene. 1994 Oct;9(10):3067-70.
10
Murine p53 is phosphorylated within the PAb421 epitope by protein kinase C in vitro, but not in vivo, even after stimulation with the phorbol ester o-tetradecanoylphorbol 13-acetate.在体外,小鼠p53可被蛋白激酶C在PAb421表位内磷酸化,但在体内即使在用佛波酯十四烷酰佛波醇乙酯刺激后也不会发生磷酸化。
Oncogene. 1996 Jul 4;13(1):205-11.

引用本文的文献

1
Protein Kinase CK2 Inhibition Represents a Pharmacological Chance for the Treatment of Skin Diseases.蛋白激酶CK2抑制是治疗皮肤病的一种药理学契机。
Int J Mol Sci. 2025 Jun 4;26(11):5404. doi: 10.3390/ijms26115404.
2
Expression, purification and characterisation of a novel mutant of the human protein kinase CK2.人蛋白激酶CK2一种新型突变体的表达、纯化及特性分析
Mol Biol Rep. 2003 Jun;30(2):97-106. doi: 10.1023/a:1023934805326.
3
Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.
蛋白激酶CK2对p53功能的依赖性调控:p53丝氨酸386(CK2)位点的磷酸化状态具有组成性且稳定的证据。
Mol Cell Biochem. 1999 Jan;191(1-2):187-99.